By Erica Teichert
(Reuters) – The Missouri Supreme Court has denied Johnson & Johnson’s bid to maneuver out of a St. Louis state courtroom hundreds of lawsuits alleging the corporate’s talc-based merchandise can improve the danger of ovarian most cancers.
The state excessive courtroom on Tuesday this week rejected an attraction by J&J <JNJ.N> in search of to switch a lot of the 2,500 lawsuits pending in state courtroom in St. Louis to courts throughout the nation the place the plaintiffs are situated.
The plaintiffs are women and their households who declare research present J&J’s Baby Powder and Shower to Shower merchandise improve the danger of ovarian most cancers when used in the vaginal space. J&J has stated extra complete research present no such hyperlink.
St. Louis has turn into the primary vacation spot for talc lawsuits nationally, and J&J has been hit with three straight jury verdicts there, totaling $195 million. The firm had hoped to reverse that development by altering the venues for the instances to probably friendlier jurisdictions.
In September, a state courtroom decide in New Jersey, the place J&J is predicated, dismissed two talc lawsuits towards the corporate.
J&J spokeswoman Carol Goodrich declined to touch upon the Missouri Supreme Court’s choice.
The firm had argued in courtroom filings that plaintiffs’ attorneys tainted the St. Louis jury pool by spending almost $10 million on tv commercials in the final yr, with a disproportionate quantity operating in St. Louis. Plaintiffs’ legal professionals have denied the allegation.
Ted Meadows, one of many plaintiffs’ legal professionals, stated in a press release on Wednesday that the Missouri Supreme Court affirmed plaintiffs’ proper to file their claims in a single location.
The subsequent trial is slated to start out on Feb. 6 in St. Louis. In that case, Nora Daniels of Columbia, Tennessee, alleges she used J&J Baby Powder for 36 years and was recognized with ovarian most cancers in 2013.
(Reporting by Erica Teichert)